Predictive Value of Troponin I for Acute Respiratory Distress Syndrome in Children With Shock
NCT02361840 is an observational study sponsored by Hospital Civil de Guadalajara. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies ARDS. The registry lists an enrollment of 65 participants at 1 site in 1 country. The registry lists a start date of 31 Oct 2012 and a primary completion date of 28 Feb 2015.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02361840 |
| Status | Unknown |
| Study type | Observational study |
| Lead sponsor | Hospital Civil de Guadalajara |
| Enrollment | 65 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | ARDS |
| Start | 31 Oct 2012 |
| Primary completion | 28 Feb 2015 |
| Study completion | 28 Feb 2015 |
| Last update posted | 12 Feb 2015 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- IRAM ALBERTO VILLA MANZANO, PhD., MD
University of Guadalajara
Study Director - KARLA ISIS AVILES MARTINEZ, MD
University of Guadalajara
Principal Investigator - MONICA CECILIA URIBE MERCADO, PhD., MD
Universidad de Gudadalajara
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Karla Isis Aviles Martinez
Guadalajara, Jalisco
Recruiting
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02361840
Each answer restates registry values shown on this page.
What is NCT02361840?
NCT02361840 is an observational study sponsored by Hospital Civil de Guadalajara. It studies ARDS.
Who leads NCT02361840?
The registry names IRAM ALBERTO VILLA MANZANO, PhD., MD (study director, University of Guadalajara), KARLA ISIS AVILES MARTINEZ, MD (principal investigator, University of Guadalajara) and MONICA CECILIA URIBE MERCADO, PhD., MD (study director, Universidad de Gudadalajara) as overall officials.
Where does NCT02361840 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: Mexico.
When is NCT02361840 expected to complete?
The registry lists a primary completion date of 28 Feb 2015 and a study completion date of 28 Feb 2015. The sponsor last updated the record on 12 Feb 2015.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.